George Elston, Chief Financial Officer at EyePoint Pharmaceuticals, Inc. (EYPT), bought 10,000 shares at $0.61 ($6K) on 2020-08-24, disclosed to the SEC on 2020-08-26.
Open-market purchase of $6k EYPT by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| EYPT | BUY | 2019-11-18 | $14K | — | Filing → |
| JNP | BUY | 2016-08-31 | $6K | — | Filing → |